Periostin regulates autophagy through integrin α5β1 or α6β4 and an AKT-dependent pathway in colorectal cancer cell migration

J Cell Mol Med. 2020 Nov;24(21):12421-12432. doi: 10.1111/jcmm.15756. Epub 2020 Sep 29.

Abstract

Colorectal cancer (CRC) is one of the most fatal cancers with highly invasive properties. The progression of CRC is determined by the driving force of periostin (PN) from cancer-associated fibroblasts (CAFs) in the tumour microenvironment. This present work aims to investigate autophagy-mediated CRC invasion via the receptor integrin (ITG) by PN. The level of PN in 410 clinical CRC tissues was found increased and was an independent poor prognosis marker (HR = 2.578, 95% CI = 1.218-5.457, P-value = .013) with a significant correlation with overall survival time (P-value < .001). PN activated proliferation, migration and invasion of CRC cells, but with reduced autophagy. Interestingly, the reduction of LC3 autophagic protein corresponded to the increased ability of CRC cell migration. The siITGα5-treated HT-29 and siITGβ4-treated HCT-116 CRC cells attenuated epithelial-to-mesenchymal transitions (EMT)-related genes and pAKT compared with those in siITG-untreated cells. The reduction of pAKT by a PI3K inhibitor significantly restored autophagy in CRC cells. These evidences confirmed the effect of PN through either ITGα5β1 or ITGα6β4 and the AKT-dependent pathway to control autophagy-regulated cell migration. In conclusion, these results exhibited the impact of PN activation of ITGα5β1 or ITGα6β4 through pAKT in autophagy-mediated EMT and migration in CRC cells.

Keywords: autophagy; cancer-associated fibroblast; colorectal cancer; integrin; periostin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Autophagy
  • Cell Adhesion Molecules / metabolism*
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Colorectal Neoplasms / metabolism*
  • Epithelial-Mesenchymal Transition
  • Female
  • Gene Expression Regulation, Neoplastic
  • HCT116 Cells
  • Humans
  • Integrin alpha6 / metabolism*
  • Integrin beta1 / metabolism*
  • Integrin beta4 / metabolism*
  • Integrins / metabolism*
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Phosphatidylinositol 3-Kinases / metabolism
  • Prognosis
  • Proportional Hazards Models
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Treatment Outcome

Substances

  • Cell Adhesion Molecules
  • ITGA5 protein, human
  • ITGA6 protein, human
  • ITGB4 protein, human
  • Integrin alpha6
  • Integrin beta1
  • Integrin beta4
  • Integrins
  • Itgb1 protein, human
  • POSTN protein, human
  • Protein Kinase Inhibitors
  • AKT1 protein, human
  • Proto-Oncogene Proteins c-akt